Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Ownership

<< Previous

Bullboard Posts

Next >>

Comment by AlwysLearnon Jun 23, 2020 12:04am

253 Views

Post# 31179391

RE:Ownership

Ownership & Insiders:LMNL

LIMINAL BIOSCIENCES INC

10.74 0.44 (4.2718 %)as of 3:59:36pm ET 06/22/2020

Quotes delayed at least 15 min. Log in for real time quote.

Ownership Summary

		Institutional Stock Ownership	14.2%
		Institutional Mutual Fund Ownership	--
		Mutual Fund Ownership	--
		Insider Ownership	--
		Other	85.8%

Institutional Ownership Details

Institutional Stock &
Mutual Fund Ownership: 14.2%

	Current Quarter	Previous Quarter
Institutional Share Purchases	19.7K	3.3M
Institutional Shares Sold	286.0	--
Net Institutional Shares Purchased	19.4K	3.3M
Change in Ownership	0.58%	15,077,690.91%

Top 10 Institutional Holdings by Shares Held
Name	Reporting Date	Total Holdings	Position Value	Outstanding Shares Owned
Consonance Capital Management LP	03/31/20	3.3M	$34.5M	14.04%
Morgan Stanley	03/31/20	34.9K	$366.9K	0.15%
Royal Bank of Canada	03/31/20	9.0K	$94.2K	0.04%
JP Morgan Chase & Company	03/31/20	2.5K	$25.7K	0.01%
UBS Group AG	03/31/20	1.5K	$15.6K	0.01%
Tower Research Capital LLC (TRC)	03/31/20	1.0K	$10.5K	0.00%
Bank of Montreal/Can/	03/31/20	280.0	$2.9K	0.00%
Toronto Dominion Bank	03/31/20	29.0	$304.5	0.00%
Tanaka Capital Management Inc	03/31/20	22.0	$231.0	0.00%
Citigroup Inc.	03/31/20	1.0	$10.5	0.00%